Manuel
Valladares Ayerbes
Complexo Hospitalario Universitario de Ourense
Orense, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (6)
2024
-
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study
Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2640-2651
2023
-
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
Biomedicine and Pharmacotherapy, Vol. 159
2022
-
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
British Journal of Cancer, Vol. 126, Núm. 6, pp. 874-880
2017
-
Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine/nab-paclitaxel: Results of a retrospective analysis
Journal of Cancer Research and Therapeutics, Vol. 13, Núm. 2, pp. 240-245
2013
-
Gemcitabine and capecitabine as third- or later-line therapy for refractory advanced colorectal cancer: A retrospective study
Anticancer Research, Vol. 33, Núm. 9, pp. 4089-4096
2001
-
Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma
Cancer, Vol. 91, Núm. 4, pp. 704-711